Josh Crossney also gave an informative and interesting talk titled “In the Know: Cannabis Science, QC Testing & Academic Research Updates. products for analytical cannabis testing, sample prep, and production. university programs in the world dedicated to the study of cannabis. The Cannabis Science Conference will be held August 27–29, in Portland, Oregon. in academic research and quality control (QC) testing, genomics, This year we also have technical updates from several cannabis testing labs, Additionally, many QC and research scientists lack a fundamental.
Testing QC Cannabis Academic the Know: Science, In Updates & Research
For example, a group of preschool teachers in California experienced nausea, dizziness, headache, and other symptoms after consuming brownies containing cannabis. One of the teachers had purchased the brownies from a sidewalk vendor and placed them in the breakroom Fogleman et al. In focus groups with teenagers, females who did not use cannabis expressed more concern than female cannabis users and males users and nonusers about edibles and compared them to drinks that could be spiked with drugs Friese et al.
Tragically, at least one death has occurred following ingestion of an edible cannabis product. However, having not felt intoxicated within 60 minutes, the man ate the whole cookie within 2 hours of ingesting the initial serving. Similar requirements are in place for Washington State Wash.
Another challenge related to edibles is the perception that they represent food products containing cannabis, when in reality the cannabis extracts used to produce edibles can be very different from the actual plant material used for smoking. Myriad techniques are used to extract cannabinoids from the cannabis plant in a form that can be integrated into the countless forms that edibles can take, resulting in considerable variation in the amount and homogeneity of cannabinoids that make it into the final products.
The cannabis plant contains hundreds of chemical constituents, including around cannabinoids Radwan et al. Other cannabinoids, most notably cannabidiol CBD , are believed to modulate these effects Russo, ; Schubart et al.
Yet, despite evidence of the value of including CBD in edibles, especially those intended for medicinal use, few edible manufacturers report the CBD content of their products. Further, even among products reported to contain CBD, many contain only trace amounts or none at all Vandrey et al. In fact, although the FDA has yet to acknowledge the therapeutic applications of the cannabis plant, it has issued warning letters to several manufacturers of products purported to contain CBD.
These actions by the FDA highlight the lack of consistency in formulation and labeling of cannabis products. Text , amending 1 Colo. Because cannabis is illegal at the federal level, the recreational and medicinal cannabis industries are not subject to federal quality control regulations, but rather are regulated on a state-by-state basis. Consequently, the edibles sold at medicinal and recreational dispensaries do not face the stringent quality control measures that are used to ensure the quality and consistency of medications or other legalized drugs e.
Even if accurate drug content labeling for edibles can be achieved, this information is only useful if it is used and understood by consumers. A nationally representative survey of US adults conducted by the US FDA found that 50 percent of adults reported that they often read the label on food products when buying a product for the first time and 29 percent sometimes read the label Lin et al.
Among respondents who reported that they never read labels, 59 percent strongly agreed or agreed that they do not use the information on food labels because it is too hard to understand.
This review found that consumers understand some of the more simple terms on nutrition labels but are confused by more complex information. Similar concerns have been identified when assessing consumer understanding of label information on prescription medications. Further, among patients who understood the labels, only a minority could correctly demonstrate how to take the medication.
Because cannabis is illegal at the federal level, the recreational and medicinal cannabis industries are regulated on a state-by-state basis. As of , four states Alaska, Colorado, Oregon, and Washington have legalized recreational sales and use. In Alaska, the Marijuana Control Board regulates cannabis. In , Colorado and Washington became the first states to legalize retail sale, purchase, and possession of cannabis by anyone 21 and older. After voters approved legalization, the states spent more than a year setting up regulatory frameworks to develop regulatory systems.
Each state put into place a tax structure and set up a licensing system to regulate the cultivation and distribution of cannabis products before allowing retail stores to begin selling to consumers in Oregon and Alaska are still in the process of establishing regulatory systems for legalized cannabis.
In Oregon, the sale of edibles at retail outlets began on June 2, Or. In Alaska, the first business licenses have been issued, and retail sales, including marijuana edibles, are expected to begin before the end of , once the state has completed the process of licensing testing facilities Thiessen, Although recreational cannabis policies continue to evolve, all four states with legalized retail sales require labeling of edible cannabis products.
For example, warning labels or accompanying material in the states of Colorado, Washington, and Alaska must state that cannabis has intoxicating effects 1 Colo. Washington and Oregon also require or will require that additional informational material be distributed to buyers of edibles with each sale or displayed on posters in the dispensary Wash.
Nutritional information labels for edible cannabis products also vary across states. For example, Colorado 1 Colo. All four states require that information about quality control testing be made available to the consumer 1 Colo. Furthermore, the labels, accompanying material, or information available upon request at retail stores in Colorado, Washington, and Alaska mandate disclosure of all pesticides that were used during production 1 Colo.
Each of the four states with legalized retail sales also has specific requirements about how edible cannabis products are manufactured.
All four states prohibit packaging edibles in a manner that appeals to children 1 Colo. Washington, Oregon, and Alaska each prohibit the manufacturing of edibles that are likely to appeal to children, such as candy Wash. Specifically, Washington and Oregon do not allow manufacturers to process cannabis items that are modeled after non-cannabis products consumed by children, such as cotton candy or lollipops, or that are shaped like animals, vehicles, persons, or characters Wash.
Alaska prohibits manufacturers from packaging any product in bright colors or with cartoon characters or other pictures that would appeal to children Alaska Admin.
Furthermore, pesticides are allowed under certain circumstances in all four states as long as records are kept of all pesticides used during certain stages of cultivation and manufacturing and the pesticides do not exceed the allowable amount 1 Colo. Edibles have emerged as a popular method of cannabinoid administration in the legalized cannabis market and have proven to be quite lucrative for states, dispensaries, and manufacturers. However, many questions remain unanswered regarding the basic effects of edibles and how consumers understand and use these products.
Further research into cannabinoids, and edibles in particular, is needed so that policy makers can be well informed when establishing regulations regarding the manufacture, labeling, and sale of edibles. The need for additional regulation of edibles is evident given the frequency of cannabis overdoses and accidental pediatric exposures. Such risks can be reduced through standardization of product formulations, adequate quality control measures, and appropriate product labeling.
In summary, on the production side, much remains to be done to ensure that edibles provide a consistent dosage. Barrus conducts nonclinical behavioral pharmacology and toxicology research. Capogrossi conducts economic analysis of nutrition policy, food safety regulation, food production and marketing, and related areas using econometrics, simulation modeling, statistical analysis, and other methods.
She conducts studies to assess consumer use and understanding of labeling features and response to alternative label formats. Her research also assesses the impact of educational interventions on outcomes related to healthy eating and foodborne illness prevention. His research concentrates on the etiology, correlates, and consequences of psychiatric disorders, with a particular focus on early intervention for adolescents and young adults.
Peiper works with Dr. His current work focuses on characterizing the epidemiological trends and identifying the at-risk populations for prescription drug abuse and co-occurring illicit drug use. Lefever has been conducting preclinical behavioral research for over 13 years and has been testing the effects of cannabinoids in these models extensively during the past 5 years.
Wiley , PhD, is a leading expert in behavioral pharmacology. Wiley designs and supervises a program of in vivo research at RTI International, including the synthesis and development of candidate medications and investigation of neural mechanisms underlying substance abuse.
She also conducts independent NIH grant-supported research in the area of cannabinoid pharmacology. Acts prohibited at marijuana product manufacturing facility, Alaska Admin. Acts prohibited at retail marijuana store, Alaska Admin. Marijuana inventory tracking system, Alaska Admin. Packaging and labeling, Alaska Admin. Acts not required; Acts not prohibited, Ariz.
Places of employment; Penal institutions; Incarcerated persons; Health insurance providers, Cal. Adopted emergency rule, Colo. Acts not required, acts not prohibited, Del. Medical use of marijuana; conditions of use, Haw. Cannabinoid edible labeling requirements, Or. Marijuana servings and transaction limitations, Wash. What are the recordkeeping requirements for marijuana licensees? What are the security requirements for a marijuana licensee? What is a marijuana processor license and what are the requirements and fees related to a marijuana processor license?
Prohibited acts A; Penalties, D. National Center for Biotechnology Information , U. Author manuscript; available in PMC Jan Barrus , Kristen L.
Capogrossi , Sheryl C. Cates , Camille K. Gourdet , Nicholas C. Peiper , Scott P. Novak , Timothy W. Lefever , and Jenny L. Author information Copyright and License information Disclaimer. See other articles in PMC that cite the published article. Abstract Food products containing cannabis extract edibles have emerged as a popular and lucrative facet of the legalized market for both recreational and medicinal cannabis. Introduction To provide a better understanding of the implications of increased use of edible cannabis products, we describe promises and challenges associated with use of cannabis-infused edibles and critically examine extant research on factors related to their use.
Medicinal Cannabis Use Marijuana or cannabis is the most commonly used illicit drug in the United States, with 9. Overview of Edibles Edibles are food products infused with cannabis extract.
Challenges of Edibles Despite the potential promises of edibles for treatment of a variety of ailments, there are also dangers inherent in edible use that present challenges for users and policy makers. Regulation of Edibles in States That Have Legalized Recreational Use Because cannabis is illegal at the federal level, the recreational and medicinal cannabis industries are regulated on a state-by-state basis.
Conclusions and Recommendations Edibles have emerged as a popular method of cannabinoid administration in the legalized cannabis market and have proven to be quite lucrative for states, dispensaries, and manufacturers. About the Authors Daniel G. Arizona Acts not required; Acts not prohibited, Ariz. California Places of employment; Penal institutions; Incarcerated persons; Health insurance providers, Cal.
Colorado Adopted emergency rule, Colo. Delaware Acts not required, acts not prohibited, Del. Hawaii Medical use of marijuana; conditions of use, Haw. Oregon Cannabinoid edible labeling requirements, Or. Tests show THC content in marijuana edibles is inconsistent.
Recreational marijuana legalization and the effects on child health and safety. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. American Journal of Health-System Pharmacy. The federal Cannabis Act creates a legal framework for producing, possessing and selling marijuana across Canada, meaning that each Canadian province will set its own rules to oversee its distribution, subject to federal government conditions.
Provincial and federal governments will share in the responsibility for the oversight of this new system, and will also share in the tax revenue. Different provinces are taking different approaches, similar to how alcohol purchases vary between jurisdictions. The Canadian government authorized the sale of marijuana for that purpose, while it simultaneously emphasizes that cannabis is not an approved therapeutic product. The medical market, for many, appears to simply be a means to access products for recreational, or non-medical use , and has generated wildly unsubstantiated claims about the medical merits of marijuana for conditions like autism and the treatment of cancer.
Dispensaries have appeared across Canada and the US, usually with very easy referrals for prescriptions. Some dispensaries ignore any prescription requirement entirely and will sell marijuana directly to the public without any medical assessment or advice. Should use for medical purposes be treated like recreational use, where consumers make their own selections, and purchases are taxed like other consumer products?
Or should some forms or uses of marijuana be treated like prescription drugs, where a health professional remains involved, and products may be even be covered by insurance plans?
With marijuana becoming much more accessible, physicians, other health professionals, and their patients need high-quality information about its value for different medical conditions. Now, three new documents prepared for Canadian physicians and health professionals concisely summarize the current evidence base for medical marijuana.
The argument being made by the pharmacy profession seems to be that 1 marijuana is a legitimate drug for medical purposes, and should be treated as such, which includes 2 a pharmacy and pharmacist being involved in the provision. The latter we can set aside for now, and focus first on whether or not marijuana is indeed a drug that should be treated like other prescription drugs. Before I continue, I should state my personal position on marijuana. I am fully supportive of the legalization of marijuana for recreational use and support regulation and taxation, treating it along the lines of alcohol or tobacco.
This prescription via the Smithsonian Institute could be used by physicians to prescribe alcohol for an array of ailments:. Naturally, the prescription market for alcohol disappeared once Prohibition ended. But marijuana is not alcohol. It contains an array of potentially medically useful chemical substances, several of which have been clinically investigated for the treatment of different medical conditions. As David Gorski has pointed out in previous posts , there are a number of biologically active chemicals in marijuana.
Cannabinoids are produced in the stalk, leaves, flowers, seeds and resin of marijuana plants. Marijuana can be smoked, vaporized, or eaten, among other forms of ingestion. THC is rapidly absorbed, and when inhaled, reaches the brain within minutes.
Oral absorption is lower owing to a significant reduction in available drug after passing though the liver. We find that acute CBD administration reduced the thermally-induced seizures that model febrile seizures in the early stage of DS.
Twice-daily CBD administration also reduced the frequency of spontaneous seizures that characterize the later stages of DS. Furthermore, we find that CBD rescued social interaction deficits and abnormal social responses in our DS mice. Together, our data suggest that CBD is an effective monotherapy against epileptic seizures and autism in DS. With no FDA or USDA to oversee consumer product testing, US States, growers and manufacturers are on their own to ensure properly labeled and safe product for patients and consumers are released in the marketplace.
The best science and technology is available today, so whether or not the government is watching over you, learn why safety testing for cannabis products will insure correct potency labelling, reliable brands and products, prevent product recalls and lead to an industry that can meet global standards for safety and health.
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text.
This content is not peer reviewed. All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received.
You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event. If accepted, you will also have the opportunity to record a minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
For information on becoming a sponsor or exhibitor, please click here. With over 11, employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals: Most life sciences and clinical research is done at top-tier universities, with funding from governments around the world.
For over years, Daigger Scientific has believed it is our role and responsibility to provide researchers, educators, life science, and other laboratory professionals with the very best service and quality products at a fair and reasonable price. Our associates focus on the Our reason for being is to provide you with a great assortment of the very best brand name products and to get them to you where and when you need them. Don't see what you need in our catalog or on our website?
Just call and we'll try to find it for you. That's our service promise, one that has stood the test over years in the laboratory supply business. Shimadzu provides a broad range of analytical instruments indispensable for research, development, and quality control in a variety of fields.
Our high-level, sophisticated instruments include chromatographs, spectrometers, and elemental and surface analysis systems. We specialize in continuously adjustable volume pipettes, as well as, automated solutions built upon your applications Ellutia is a leading independent manufacturer of innovative chromatography instruments.
To supplement our own proprietary product range, we have incorporated the best available external technologies to enhance our product portfolio and now offer a wide range of products including autosamplers, GC inlets, detectors, analysers, software, hardware and accessories. We have become known for our personalised, responsive service and our ability to provide customised solutions to our customers' challenges.
Offering an ideal combination of agility and speed of service with a global outlook and industry-shaping technological innovations, we have become the partner of choice for hundreds of customers. If you are looking for something different in a market often dominated by rigid mass producers, Ellutia is the perfect analytical partner for you. To discuss your analytical challenges, contact us today.
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Terpenes and Testing Magazine Terpenes and Testing Magazine provides the scientific cannabis world with cutting edge reporting on news, politics, and methods regarding cannabis testing, marijuana extractions, and everything in between.
With an emphasis on science and an infusion of culture we pride ourselves Our magazine is distributed to every laboratory and extraction facility from the United States to Israel and everywhere in between. Additionally, the digital copy can be found for sale in the Apple store and the Google Play store.
We also post daily content on our blog that reaches an even wider spectrum of viewers keeping them educated on the latest in business, science, and news related to the marijuana industry. We're excited to stand alone in this publishing space as the only print magazine reporting on this crucial space in the legal cannabis market. Welcome to The Cannabis Reporter, an online media outlet, and syndicated radio show educating millions on the benefits of medical cannabis.
For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here. To download the Program Committee brochure here. Fellowship in Metabolic and Nutritional Medicine in During his 34 years in practice, he has worked in primary research at UCI, Dept.
Integrating both legacy and proprietary technologies, Miradati helps Up until , it's safe to say Cersosimo had, at best, an agnostic view of the medicinal benefits of the popular recreational drug. That would soon change after he was introduced to the family of Hannah Shuker, an 11 year-old girl with severe intractable epilepsy.
Hannah instantly captured Cersosimo's heart and the desire to help save her life forever changed his. Witnessing first hand how profoundly cannabis could improve Hannah's condition, Cersosimo made it his mission to help get such medicine into the hands of other patients and families, equally desperate for hope.
These efforts led him in to found the Pennsylvania Medical Cannabis Society PAMCS , the Commonwealth of Pennsylvania's largest organization for professionals, educators and leaders in the industry. It should come as no surprise that PAMCS' and Cersosimo's advocacy efforts were instrumental in 's successful legalization campaign.
Today, Cersosimo is committed to forging partnerships that improve the capture and analysis of medical cannabis data. Cersosimo is passionate about developing solutions that will shape the industry and help more patients like Hannah around the world.
With that operating vision at its core, Cersosimo's Keystone Integrated Care, was recently awarded multiple licenses to operate medicinal dispensaries throughout southwestern Pennsylvania. A serial entrepreneur as far back as his days studying Psychology at West Virginia University, Cersosimo founded Webbula, a data-centric technology company. Minimum x Video Card: If it is, please turn off the VPN while attending the virtual event.
MAR 28 - 29 Founder and Chief Scientist at Eden Labs. Applications Scientist at Shimadzu. Professor, Department of Management, Laval University. Laboratory Manager, Pacific Agricultural Laboratory. Senior Scientist at Neptune and Company, Inc. Pharmacist, Medical Cannabis Research Australia. SEP 14, An industry leader in delivering instrument systems, reagents, and services to life science researchers,Beckman Coulter Life Sciences helps enable new discoveries in biology-based research NOV 02, This premiere venue discusses the latest advances in clinical diagnostics, research and medicine.
NOV 08, Clinical diagnostics is an ever-changing field of medicine and research, challenged wit MAY 28, Clinical Diagnostics and Research. The theme of this conference is a range of medical and clin MAR 19, BioConference Live makes it easier and more cost-effective for the neuroscience research community to come together online through live video webcasts and real-time networking.
NOV 11, The event is now available on-demand and you can attend sessions including keynotes MAR 28, Review the current status of the opiate crisis in the United States Explore the results of a recent study examining cannabis as a treatment for noncancer pain Identify approaches to use and standardized formulas to deliver cannabis in a reliable way Discuss the implications of adding cannabis to a pain management strategy.
Extraction and the Labeling of Cannabis Products. Be able to describe and compare the benefits and drawbacks of different extraction methods Be able to examine and assess cannabis products based on labeling and other product information.
Recognizing the candidates for cannabis therapy Understanding the basic principles in cannabis therapy. Controlling Terpenes and Cannabinoids in Flower and Extract. Drug Development and Approval in the U. Regulatory Challenges and Opportunities for Cannabis Therapies. Sampling for Cannabis Testing. Role of sampling within the cannabis industry and its importance.
Understand the process in which cannabis is analyzed for potency Identify the potential sources of error that may arise during potency testing. Medical Cannabis in Pediatrics. Herah Osborne Advocacy Founder, Strainz. Economies of Scale in Cannabis: Should everyone own their own SFE or will it be less expensive to send it out to large scale processors?
What is the basic process of growing cannabis indoors How do factors like plant genetics, growing strategy, and government regulation impact the most efficient way to allocate space inside and indoor cannabis farm. To understand the value proposition of implementing automation into a regulated environment To learn how leveraging automation tools can not only standardize processes but cut costs To see that deploying flexible solutions can facilitate regulatory compliance quickly and efficiently.
MAR 29, Measurement of Pesticides in Cannabis. Understand some reasons why pesticides are used and why testing is needed in cannabis Understand the general pesticide testing workflow for cannabis samples. He will discuss such areas as: Cannabis safety statistics compared to other drugs Where cannabis sits on the addiction scale Pharmacokinetics comparing smoked versus oral Drug interactions of cannabis Indications for medicinal cannabis and the evidence base Research into new medical uses Dosage forms Learning Objectives: Medical uses of cannabis Cannabis pharmacokinetics and the difference between smoked and oral.
Selecting a Safe and Clean Cannabis Product. Learn how to obtain a safe, clean cannabis product Learn about different types of lab testing for cannabis Learn basics about different extractions methods for medical cannabis products. Better Science - Better Quality of Life. For years the cannabis plant has been demonized, made illegal, and kept from researchers.
The Road to Consensus Standards. Approaches for reducing the impact of sample sample background in the analysis of cannabis plant material for pesticides and mycotoxins Easy and fast sample preparation and analysis approaches for potency, residual solvents and terpene analysis. To highlight the different sources of variability that influence numbers placed on cannabis-product labels To illustrate case-studies witnessed during the audits of labs, and showcase how RJ Lee Group has assisted labs in addressing compliance issues.
Exploring co2 and Ethanol Extraction. A basic understanding of Ethanol and co2 extraction and the equipment utilized to perform these types of extraction The ability to discern what type of extraction methodology and equipment that best suits the needs of your business model. Pediatric Medical Cannabis Guidance. Steps to take to get your child started on Medical Cannabis Important Things to think about when starting your child on Medical Cannabis.
Rick Jordan Sponsored By: Global Cannabis Regulation and Testing Standards. As States and Countries Legalize, learn why Cannabis Testing is Integral to a successful cannabis industry - the what and why Like other consumer industries, consumers will demand safe, tested and properly labeled cannabis.
Advanced science and technology is here and available today to insure accurately labeled and safe products. Learn how to be ahead of consumer demand as this industry grows out of infancy and into maturity. Cannabis Therapies for Diseases. Integrating both legacy and proprietary technologies, Miradati helps facilitate this rapidly developing field of study, producing quantifiable data that more accurately measures patient outcomes, reduces prescribing errors, and lowers patient costs.
Russ sits on the ASTM D37 committee for writing cannabis industry standards and is passionate about developing solutions that will shape the industry. His medial experience includes 26 years in emergency medicine and private general practice that includes the medical use of cannabis since He continues in a consultation practice in northern California with face-to-face, telephone, and on-line consultations for the use of cannabis as medicine.
Hergenrather's practice, research, and teaching focus on the medicinal use of cannabis through a wide range of conditions and age groups - from infants to elder care. He is a founding member and current president of the Society of Cannabis Clinicians, a non-profit corporation dedicated to quality patient care, education, and clinical studies. He also serves as an expert witness and consultant to local government and industry in supporting safe access to measured cannabis medicines.
Eden Labs evolved from Fritz's research about remote indigenous peoples using botanicals to cure illness. Early findings ignited a spark to unlock more secrets of botanicals using extraction and distillation. Curiosity became dedication as he pursued finding and producing more healthful, natural products for human health and consumption.
Experimentation continued-exploring the use of solvents, pressures, and temperatures-leading to Eden Labs' first Supercritical CO2 extraction machine, specifically engineered for small business, which Eden still serves but has organically expanded to include industrial plants. Fritz's passion makes Eden Labs a trusted partner for those entering the new field of extraction and distillation of cannabis and other botanicals for the health of the world.
For the last 30 years, Dr. While earning his doctorate in , Dr. Suprex was the first company to focus only on supercritical fluids. Chordia left Suprex in and formed Thar Technologies. Through his technological and commercial leadership, Dr.
Chordia has taken Thar from one employee to a global leader in its field. This transformation has led to the creation of several spin offs, including: Some examples of Thar's involvement in supercritical fluid process and equipment technologies over the years are natural pharmaceutical and spice extraction, drug purification and design, coatings, electronics cleaning, cooling, advanced biofuels and a host of other applications and equipment technologies.
In particular, extraction of cannabis and the separation of individual cannabinoid for large scale production.
Three Gurus of Cannabis Analysis
Cannabis Sciences is a growing field of medicine and research, with a regulatory landscape that is By bringing together cannabis industry experts, instrument manufacturers, testing labs, research scientists, medical Current Landscape . As a medicine it is useful to know the basic principles of cannabinoid therapy. Visit us at the Cannabis Science Conference Booth # . PTSD Study Advances Medical Cannabis Research. the latest methods, brush up on analytical science fundamentals, learn the scientific world we know well with the cannabis industry we are .. Quality Control Testing in Regulated Markets. We have blended science and regulatory factors in order to provide an overview . edibles, which account for a substantial percentage of current cannabis use in both Additional research finds that edibles are especially popular with medicinal .. All four states require that information about quality control testing be made.